Unique ID issued by UMIN | UMIN000032752 |
---|---|
Receipt number | R000037354 |
Scientific Title | Suppressive effect of test food on the postprandial triglyceride level -A randomized, double blind, placebo controlled, cross-over study- |
Date of disclosure of the study information | 2018/05/29 |
Last modified on | 2018/10/05 18:49:47 |
Suppressive effect of test food on the postprandial triglyceride level -A randomized, double blind, placebo controlled, cross-over study-
Suppressive effect of combination of test food on the postprandial triglyceride level
Suppressive effect of test food on the postprandial triglyceride level -A randomized, double blind, placebo controlled, cross-over study-
Suppressive effect of combination of test food on the postprandial triglyceride level
Japan |
None
Adult |
Others
NO
To investigate the effect of test food on the postprandial triglyceride level of subjects.
Efficacy
Exploratory
Not applicable
Area under the curve for postprandial serum triglyceride level
Area under the curve for Remnant-like particle cholesterol, and serum triglyceride levels and Remnant-like particle cholesterol of before, 2, 3, 4 and 6 hours after high fat meal ingestion.
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
NO
NO
NO
No need to know
2
Treatment
Food |
Intake of test food, and then ingestion of placebo after wash out period.
Intake of placebo, and then ingestion of test food after wash out period.
20 | years-old | <= |
65 | years-old | > |
Male and Female
1)Males and females 20 to 64 years of age.
2)Subjects whose fasting serum triglyceride levels are less than 200 mg/dL.
1)Subjects who has serious medical history or who had digestive tract resection surgery.
2)Subjects who routinely use medicine, supplements, FOSHU and/or health food which affect to result of the study.
3)Subjects who have allergy to the test food or high fat meal and have extreme lactose intolerance or diarrhea.
4)Subjects who are planning to become pregnant after informed consent for the current study or are pregnant or lactating.
5) Heavy use of alcohol or excessive smokers
6) Subjects who is considered to be inappropriate to attend the present study by the investigator.
50
1st name | |
Middle name | |
Last name | Hideaki Hoshino |
Medical Corporation Jikokai Shiroishi Internal Medicine Clinic
General Medicine Clinical Departments Internal Medicine Respiratory Medicine Allergy
7-10-30 Chuo-1 jo, Shiroishi-ku, Sapporo, Hokkaido, Japan
011-868-2711
shiroishi@jikkai.or.jp
1st name | |
Middle name | |
Last name | Kosuke Suzuki |
Medical Corporation Jikokai
Clinical Trial Division
7-10-30 Chuo-1 jo, Shiroishi-ku, Sapporo, Hokkaido, Japan
011-868-2711
suzuki-jikoukai@e-mail.jp
FANCL Corporation
Research Institute
None
Profit organization
Japan
NO
医療法人社団 慈昂会 白石内科クリニック
2018 | Year | 05 | Month | 29 | Day |
Unpublished
Completed
2018 | Year | 05 | Month | 21 | Day |
2018 | Year | 06 | Month | 11 | Day |
2018 | Year | 05 | Month | 29 | Day |
2018 | Year | 10 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037354